Melanie E. Davis
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Plant tissue culture and regeneration
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 4
- Plant tissue culture and regeneration 4
- Protein Degradation and Inhibitors 2
- Phytochemical compounds biological activities 2
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- David Lucas (12 shared papers)Michael R. Grever (8 shared papers)John C. Byrd (9 shared papers)Mark R. Parthun (6 shared papers)A. Raymond Miller (3 shared papers)John C. Reed (2 shared papers)Joseph Wickham (2 shared papers)John C. Byrd (2 shared papers)
- Journals
- Blood (6 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)Cancer (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Melanie E. Davis
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Genetics 330
- Molecular Biology 854
- Hematology 132
- Pathology and Forensic Medicine 169
- Immunology 168
Countries citing papers authored by Melanie E. Davis
This map shows the geographic impact of Melanie E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie E. Davis more than expected).
Fields of papers citing papers by Melanie E. Davis
This network shows the impact of papers produced by Melanie E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie E. Davis. The network helps show where Melanie E. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Melanie E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 156 | |
| 2 | 2003 | 142 | |
| 3 | 2009 | 138 | |
| 4 | 2004 | 115 | |
| 5 | 2009 | 94 | |
| 6 | 2003 | 80 | |
| 7 | 2011 | 63 | |
| 8 | 2008 | 60 | |
| 9 | 2010 | 43 | |
| 10 | 1972 | 40 | |
| 11 | 1991 | 39 | |
| 12 | 2013 | 31 | |
| 13 | 2007 | 28 | |
| 14 | 2016 | 22 | |
| 15 | 1991 | 22 | |
| 16 | 1992 | 20 | |
| 17 | 2009 | 17 | |
| 18 | 2006 | 16 | |
| 19 | Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study. | 1987 | 10 |
| 20 | 1980 | 6 |
About Melanie E. Davis
Melanie E. Davis is a scholar working on Molecular Biology, Genetics, Plant Science, Pathology and Forensic Medicine and Oncology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (4 papers), Plant tissue culture and regeneration (4 papers), Plant Genetic and Mutation Studies (3 papers), Protein Degradation and Inhibitors (2 papers), Phytochemical compounds biological activities (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Genetics (330 citations), Molecular Biology (854 citations), Hematology (132 citations), Pathology and Forensic Medicine (169 citations) and Immunology (168 citations). Melanie E. Davis has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include David Lucas, Michael R. Grever, John C. Byrd, Mark R. Parthun, A. Raymond Miller, John C. Reed, Joseph Wickham, John C. Byrd, Andrew P. Mone and Shinichi Kitada. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Clinical Cancer Research, British Journal of Haematology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.